MEIP - MEI Pharma rejects unsolicited bid to take company private

2023-06-01 08:47:48 ET

• MEI Pharma's ( NASDAQ: MEIP ) board has rejected an unsolicited offer from a group wanting to take the company private.
• The board said that the bid "significantly undervalues the Company, is not superior to the proposed transaction with Infinity Pharmaceuticals, Inc. ( INFI ) and does not provide a basis for discussions regarding an alternative transaction."
• A group headed by Anson Advisors and Cable Car Capital on May 30 offered not less than $8 in cash per share as well as a contingent value right to receive 80% of the net proceeds payable from any license or selling of the Company’s clinical assets.
• The MEI ( MEIP ) and Infinity ( INFI ) merger is expected to close mid year .

For further details see: